AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25695189
Drug: Ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine with 150 μg dexmedetomidine (RD150)
Trial: 25695189
Drug: Ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine with dexmedetomidine (all doses)
Trial: 20968112
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg three times a day)
Trial: 18321486
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (incremental dose)
Trial: 18321486
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of metformin and clomiphene citrate
Trial: 17204136
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitor (SSRI) plus general practitioner (GP) supportive care
Trial: 11587494
Drug: Naratriptan 0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naratriptan 0 mg
Trial: 11587494
Drug: Naratriptan 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naratriptan 20 mg
Trial: 11587494
Drug: Sub-D-optimal design
RxNorm normalized name: Water-D sub(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-D-optimal design with Naratriptan 0 mg
Trial: 11587494
Drug: Sub-D-optimal design
RxNorm normalized name: Water-D sub(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-D-optimal design with Naratriptan 10 mg
Trial: 9154396
Drug: Lamisil DermGel
RxNorm normalized name: Lamisil
DrugBank: Terbinafine (DB00857)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamisil DermGel (terbinafine 1% emulsion gel) applied once daily for 7 days
Trial: 9154396
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel applied once daily for 7 days
Trial: 7957547
Drug: Flumequine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumequine (400 mg, three times daily for 5 days)
Trial: 7957547
Drug: Theophylline (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (single i.v. dose)
Trial: 3819220
Drug: Grass-pollen immunotherapy
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass-pollen immunotherapy (IT)
Trial: 29652278
Drug: Glargine +
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Glargine + human insulin infusion during perioperative period
Trial: 29652278
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline + human insulin infusion during perioperative period
Trial: 20951370
Drug: Hydrocortisone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (30 mg intravenous)
Trial: 12410536
Drug: induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: induction chemotherapy arm (n = 86)
Trial: 12410536
Drug: all patients
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: all patients (regardless of treatment group)
Trial: 7617555
Drug: Erythromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (500 mg x 3)
Trial: 2501544
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for premenopausal patients
Trial: 2501544
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy for postmenopausal patients
Trial: 2501544
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy for receptor-positive patients
Trial: 2501544
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for receptor-negative patients
Trial: 23262931
Drug: Chemotherapy after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy after downregulation (estradiol less than 50 pg/mL) by GnRH antagonist and agonist (arm II)
Trial: 23262931
Drug: Chemotherapy after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy after downregulation with GnRH agonist (arm IV)
Trial: 23262931
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (arm I)
Trial: 9667265
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (arm III)
Trial: 21878782
Drug: Telephone depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone depression care management + treatment as usual (TAU)
Trial: 11387608
Drug: 4F power
RxNorm normalized name: 4F-PCC
DrugBank: Factor IX Complex (Human) (DB11330)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4F power injection (Acist)
Trial: 9612618
Drug: Adjuvant multimodal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant multimodal treatment including pre- and postoperative chemoradiation, intraoperative radiotherapy (IORT), adjuvant chemotherapy, and regional infusion therapy.
Trial: 8070499
Drug: Ibuprofen syrup
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen syrup (7.5 mg/kg)
Trial: 8070499
Drug: Acetaminophen syrup
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen syrup (10 mg/kg)
Trial: 8070499
Drug: Both ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Both ibuprofen and acetaminophen
Trial: 21816996
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nonsteroidal anti-inflammatory drugs, orthotics, and home exercise program without dynamic splinting)
Trial: 16390354
Drug: mequitazine 10
RxNorm normalized name: mequitazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mequitazine 10 mg q.a.m.
Trial: 16390354
Drug: dexchlorpheniramine Repetab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexchlorpheniramine Repetab 6 mg b.i.d.
Trial: 16390354
Drug: cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cetirizine 10 mg q.a.m.
Trial: 14504025
Drug: TREAT (Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TREAT (Treatment Research Experiences and Attitudes Task) - a 50-item patient-administered measure of attitudes
Trial: 10917410
Drug: Risperidone 0.5
RxNorm normalized name: risperidone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 0.5 mg once daily at night, increased to a maximum of 2 mg/day
Trial: 2451549
Drug: Conventional doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doses (1 mg/kg/day) of corticotherapy
Trial: 2451549
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses (0.25 mg/kg/day) of corticotherapy
Trial: 28585260
Drug: Optimel Antibacterial
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimel Antibacterial Manuka Eye Gel (98% Leptospermum species honey) plus conventional therapy, n = 37
Trial: 28585260
Drug: Optimel Manuka
RxNorm normalized name: GLYCERIN 2 mg in 1 mL OPHTHALMIC GEL [Optimel Manuka Forte Eye Gel]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimel Manuka plus Lubricant Eye Drops (16% Leptospermum species honey) plus conventional therapy, n = 37
Trial: 28585260
Drug: Conventional therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy, n = 40
Trial: 12938052
Drug: IFN-alpha2b (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN-alpha2b (low dose) 3 million IU, twice a week for 2 years
Trial: 12938052
Drug: IFN-alpha2b (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN-alpha2b (high dose) 10 million IU, twice a week for 2 years
Trial: 9183072
Drug: Concise bonding
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concise bonding agent
Trial: 9183072
Drug: Transbond bonding
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transbond bonding agent
Trial: 16875153
Drug: Zafirlukast 20
RxNorm normalized name: zafirlukast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast 20 mg twice daily for 4 days
Trial: 9017562
Drug: Stage-based telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stage-based telephone counseling (3 post-treatment calls)
Trial: 6134549
Drug: Opiate analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opiate analgesics
Trial: 27596284
Drug: 30 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/day of pecan nuts
Trial: 27596284
Drug: 30 ml/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml/day of olive oil
Trial: 25730928
Drug: Enhanced external
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced external counterpulsation (EECP) combined with gaseous carbon dioxide baths and infrared laser therapy
Trial: 15813818
Drug: Mepolizumab (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab (750 mg, two doses, 1 week apart)
Trial: 12014211
Drug: Antimicrobial prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial prophylaxis (AP) with orally absorbable antibiotics: 250 mg ciprofloxacin twice a day, 150 mg roxithromycin twice a day, 50 mg fluconazole once a day
Trial: 10468294
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha-2b (IFN-alpha-2b) intravenous: 20 MIU m(−2), 5 days a week for 4 weeks; subcutaneous: 10 MIU m(−2), 3 times a week for 11 months
Trial: 10468294
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha-2b (IFN-alpha-2b)
Trial: 538418
Drug: Guaiacolic ester
RxNorm normalized name: guaiacol
DrugBank: Guaiacol (DB11359)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guaiacolic ester of acetylsalicylic acid (ASA-G)
Trial: 19717853
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin (10 units, 0.1 cc) applied twice daily
Trial: 19717853
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 cc saline 0.9% for each 10 cm2 of wound) applied twice daily
Trial: 18520804
Drug: Tegafur-uracil (UFT)
RxNorm normalized name: tegafur / uracil
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegafur-uracil (UFT) 200 mg/m2 twice daily from day 1 through 14 plus gemcitabine 900 mg/m2 on days 8 and 15, repeated every 3 or 4 weeks
Trial: 18520804
Drug: Tegafur-uracil (UFT)
RxNorm normalized name: tegafur / uracil
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegafur-uracil (UFT) and gemcitabine combination chemotherapy
Trial: 8527689
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of talinolol (30 mg)
Trial: 8527689
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of talinolol (50 mg)
Trial: 137218
Drug: Aminophylline (0.24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (0.24 g i.v.)
Trial: 137218
Drug: Diprophylline (0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diprophylline (0.28 g i.v.)
Trial: 137218
Drug: Hexoprenaline (0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexoprenaline (0.005 mg i.v.)
Trial: 137218
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (0.08 mg)
Trial: 29451036
Drug: Chondroitin Sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin Sulfate (CS) 800 mg/day
Trial: 18433755
Drug: Oral anti-diabetic
RxNorm normalized name: Diabetic Tussin EX Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anti-diabetic agents
Trial: 18433755
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (in vitro)
Trial: 18433755
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (before and after treatment)
Trial: 16988562
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan (3 mg in 1 mL saline)
Trial: 16988562
Drug: Oral sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sumatriptan (50 mg twice daily for 1 week)
Trial: 12636950
Drug: Docosahexaenoic acid
RxNorm normalized name: docosahexaenoic acid
DrugBank: Doconexent (DB03756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docosahexaenoic acid (33 or 133 mg) supplementation from eggs until parturition
Trial: 8851608
Drug: Atevirdine alone
RxNorm normalized name: Atevirdine
DrugBank: Atevirdine (DB12264)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atevirdine alone (treatment B)
Trial: 8851608
Drug: Concurrent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent administration of didanosine and atevirdine (treatment C)
Trial: 6337198
Drug: Aqueous solution
RxNorm normalized name: Zephiran Chloride 1:750 Antiseptic Aqueous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous solution of mixed-grass extract
Trial: 6337198
Drug: Histamine solution
DrugBank: Histamine (DB05381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Histamine solution (placebo)
Trial: 30269312
Drug: Tafenoquine (TQ)
DrugBank: Tafenoquine (DB06608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tafenoquine (TQ) 400 mg for 3 days
Trial: 30269312
Drug: Chloroquine (CQ)
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine (CQ) 1500 mg for 3 days then Primaquine (PQ) 15 mg for 14 days
Trial: 27410490
Drug: ASP2408 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2408 3.0 mg/kg subcutaneously every 4 weeks
Trial: 27410490
Drug: ASP2408 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2408 3.0 mg/kg subcutaneously every 2 weeks
Trial: 27410490
Drug: ASP2408 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP2408 (various doses)
Trial: 20402591
Drug: Azithromycin 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 2.0 g orally as a single dose
Trial: 20402591
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin G 2.4 million units intramuscularly
Trial: 16444089
Drug: Local decongestants
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local decongestants
Trial: 16444089
Drug: Local decongestant
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local decongestant followed by nasal dilator
Trial: 16444089
Drug: Local decongestant
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local decongestant followed by placebo strip
Trial: 11910671
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg isoflavone extract
Trial: 11910671
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg isoflavone extract
Trial: 31096724
Drug: SOC+C+P (chlorpromazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SOC+C+P (chlorpromazine 12.5 mg BID + promethazine 12.5 mg BID or chlorpromazine 25 mg BID + promethazine 25 mg BID) for 2 weeks
Trial: 32615
Drug: Bacampicillin 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 1600 mg twice daily
Trial: 32615
Drug: Bacampicillin 800
RxNorm normalized name: bacampicillin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacampicillin 800 mg three times daily
Trial: 32615
Drug: Oral ampicillin
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ampicillin 1000 mg three times daily
Trial: 19821718
Drug: CUF2 herbal
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CUF2 herbal formula (0.619-g capsule daily for 6 months)
Trial: 16423088
Drug: Esomeprazole 2
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 2 x 40 mg, levofloxacin 2 x 500 mg, and amoxicillin 2 x 1 g for 7 days (ELA)
Trial: 16423088
Drug: Esomeprazole 2
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 2 x 20 mg, clarithromycin 2 x 500 mg, and amoxicillin 2 x 1 g for 7 days (ECA)
Trial: 15801915
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg on-demand treatment
Trial: 3874037
Drug: Fluoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (30 or 60 mg)
Trial: 1516463
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 20 mg/kg b.i.d. for 7 days
Trial: 1516463
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 20 mg/kg b.i.d. for 10 days
Trial: 1516463
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 10 mg/kg b.i.d. for 10 days
Trial: 6661468
Drug: Low-dose naloxone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose naloxone infusion
Trial: 6661468
Drug: High-dose naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose naloxone infusion
Trial: 22270204
Drug: Dynamiclear formulation
RxNorm normalized name: Dynamiclear Oro
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamiclear formulation (copper sulfate pentahydrate and Hypericum perforatum)
Trial: 20969660
Drug: DGE (dermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DGE (dermal gel extra)
Trial: 9665673
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 2 IU/m2 for 12 months
Trial: 21784603
Drug: Conservative medical
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative medical treatment (Control)
Trial: 15278085
Drug: Nebulized lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized lidocaine (4 mL 10%)
Trial: 15278085
Drug: Placebo (nebulized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (nebulized normal saline solution)
Trial: 11376302
Drug: Carvedilol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (mean daily dose: 58 ± 1 mg)
Trial: 11376302
Drug: Metoprolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (mean daily dose: 162 ± 1 mg)
Trial: 9292587
Drug: Zidovudine 100
RxNorm normalized name: zidovudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine 100 mg every 4 hours (regimen A)
Trial: 9292587
Drug: Zidovudine 300
RxNorm normalized name: zidovudine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine 300 mg every 12 hours (regimen B)
Trial: 8501929
Drug: Platelet rich
RxNorm normalized name: Platelet Rich Plasma
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet rich plasma infusion after heparin reversal
Trial: 8501929
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no platelet rich plasma infusion)
Trial: 3682857
Drug: Right atrial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right atrial injection of protamine
Trial: 3682857
Drug: Left atrial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left atrial injection of protamine
Trial: 3682857
Drug: Aortic injection
RxNorm normalized name: chloroxylenol / hydrocortisone / pramoxine hydrochloride Otic Solution [Cortic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aortic injection of protamine
Trial: 29515279
Drug: Etodolac 400
RxNorm normalized name: etodolac 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac 400 mg b.i.d
Trial: 29515279
Drug: Lornoxicam 8
RxNorm normalized name: lornoxicam 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 8 mg b.i.d
Trial: 29515279
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg t.i.d